UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform
UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform.
UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform.
A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the infrastructure to properly test and validate them before they become embedded in patient care.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore.
UPMC Enterprises and Redesign Health launched a new startup named Glimmer Health. The company partners with primary care providers to improve pain management using a personalized, holisitic approach.
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.
This year's ViVE conference was full of announcements — from acquisitions to rebrands to product launches. This list compiles short summaries for seven of the conference’s most notable announcements.
Arrive Health (formerly RxRevu) recently acquired a suite of technology developed at UPMC. The technology suite includes an AI-powered chatbot and customer relationship management platform, both designed to support improved medication adherence and prescription capture rates.
The company, which is called Infectious Disease (ID) Connect, aims to virtually connect UPMC infectious disease specialists to other hospitals.
Rasu Shrestha, UPMC's chief innovation officer and executive vice president of UPMC Enterprises, will join Atrium Health as its chief strategy officer in February 2019.
Though terms of the deal were not disclosed, the organizations said the combined company will serve almost 100 facilities in 14 states.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center — UPMC Enterprises.
The president of UPMC's venture arm and it's innovation chief were among panelists explaining the benefits of having a hospital as an investor while asking for help from startups to transform the customer experience in healthcare.
Microsoft chose UPMC Enterprises as its initial innovation partner for Healthcare NExT as the Redmond Empire takes aim at the growing influence of IBM Watson Health, Salesforce, Apple's ResearchKit and other tech heavyweights.
UPMC Enterprises is the innovation and commercialization arm of the University of Pittsburgh Medical Center and it has launched about 60 healthcare companies to date.
Cernostics is part of the wave of oncology that looks at cancer at the tissue and cellular level instead of focusing on the location of the tumor — lung, stomach, pancreas.